NO trigger early preconditioning: relationship to mitochondrial K ATP channel. Am J Physiol Heart Circ Physiol 284: H299-H308, 2003. First published September 26, 2002 10.1152/ajpheart.00706.2002Reactive oxygen species (ROS) and nitric oxide (NO) are implicated in induction of ischemic preconditioning. However, the relationship between these oxidant signals and opening of the mitochondrial ATP-dependent potassium (K ATP) channel during early preconditioning is not fully understood. We observed preconditioning protection by hypoxia, exogenous H 2O2, or PKC activator PMA in cardiomyocytes subjected to 1-h ischemia and 3-h reperfusion. Protection was abolished by K ATP channel blocker 5-hydroxydecanoate (5-HD) in each case, indicating that these triggers must act upstream from the K ATP channel. Inhibitors of NO synthase abolished protection in preconditioned cells, suggesting that NO is also required for protection. DAF-2 fluorescence (NO sensitive) increased during hypoxic triggering. This was amplified by pinacidil and inhibited by 5-HD, indicating that NO is generated subsequent to K ATP channel activation. Exogenous NO during the triggering phase conferred protection blocked by 5-HD. Exogenous NO also restored protection abolished by 5-HD or N -nitro-L-arginine methyl ester in preconditioned cells. Antioxidants given during pinacidil or NO triggering abolished protection, confirming that ROS are generated by K ATP channel activation. Coadministration of H 2O2 and NO restored PMA-induced protection in 5-HD-treated cells, indicating that ROS and NO are required downstream from the K ATP channel. We conclude that ROS can trigger preconditioning by causing activation of the K ATP channel, which then induces generation of ROS and NO that are both required for preconditioning protection. hydrogen peroxide; nitric oxide; ischemia; cardiomyocytes PRECONDITIONING CONFERS PROTECTION against ischemiareperfusion injury in the heart. After a brief triggering stimulus is applied, the "early window" of protection begins within minutes and lasts for several hours. The persistence of protection after removal of the trigger indicates that a signal transduction pathway has been activated. Numerous triggers of preconditioning have been identified, including brief hypoxia/ischemia, opioids, ACh, bradykinin, activators of PKC, and pharmacological agents that activate the mitochondrial ATPdependent potassium (mitoK ATP ) channel (10, 13, 15, 16, 26, 39, 50) . However, the signal transduction sequence activated by these triggers is not fully understood.
hydrogen peroxide; nitric oxide; ischemia; cardiomyocytes PRECONDITIONING CONFERS PROTECTION against ischemiareperfusion injury in the heart. After a brief triggering stimulus is applied, the "early window" of protection begins within minutes and lasts for several hours. The persistence of protection after removal of the trigger indicates that a signal transduction pathway has been activated. Numerous triggers of preconditioning have been identified, including brief hypoxia/ischemia, opioids, ACh, bradykinin, activators of PKC, and pharmacological agents that activate the mitochondrial ATPdependent potassium (mitoK ATP ) channel (10, 13, 15, 16, 26, 39, 50) . However, the signal transduction sequence activated by these triggers is not fully understood.
Reactive oxygen species (ROS) have been implicated as participants in the signaling pathway involved in preconditioning triggering (1, 2, 4, 23, 41) . We previously reported (42, 50) that exogenous H 2 O 2 induces preconditioning in cardiomyocytes and that mitochondrial ROS are involved in the triggering by hypoxia or by ACh administration. However, an interesting controversy has developed regarding the relationship between the mitoK ATP channel activation and the ROS signal during triggering. On one hand, Pain et al. (31) and Forbes et al. (6) showed that activation of the mitoK ATP channel elicits an increase in ROS generation that is required for preconditioning protection. Moreover, ROS generation during ACh triggering is abolished when the K ATP channel is inhibited, indicating that ROS signaling occurs as a consequence of channel activation (50) . On the other hand, K ATP channel inhibitors given during hypoxic triggering abolished protection without attenuating the ROS signal (43) . These findings suggest that oxidant signals may potentially participate at multiple steps during triggering by 1) contributing to the activation of the mitoK ATP channel during hypoxic triggering and 2) being generated as a consequence of mitoK ATP opening during all forms of triggering. In either case, although ROS appear to play a central role in the signaling associated with triggering, the relationship between the mitoK ATP channel and ROS generation during the triggering of early preconditioning is not fully understood.
Reactive nitrogen species (RNS) have also been suggested to participate in the intracellular signaling during preconditioning triggering (19, 29, 34, 49) . However, the requirement for RNS in the triggering of preconditioning is controversial, as some groups find evidence for the involvement of nitric oxide (NO) during the early window of protection (21, 32 ) but others do not (27) . In cardiomyocytes, inhibition of NO synthase (NOS) with N -nitro-L-arginine methyl ester (L-NAME) did not abolish the ROS signal during hypoxic triggering (42) , which suggests that NO is not required for ROS generation during hypoxic triggering. However, NOS inhibitors did abolish the ROS signal during ACh triggering, and they abrogated its protective effects (16) . Therefore, the role of NO in early preconditioning is not fully clear, and the relationships among RNS, ROS, and the K ATP channel are not fully understood.
To clarify these relationships during the triggering phase of early preconditioning, this study evaluated their interactions in the context of a model ( Fig. 1 ) based on previous work from other laboratories (for reviews, see Refs. 5, 9, 18, 22, 28, 30) and our own. The model proposes that ROS are required at two separate steps in the triggering process and that NO is required for events occurring downstream from the K ATP channel. According to this model, preconditioning triggering requires both ROS and RNS. We propose that ROS are required both upstream and downstream of mitoK ATP channel activation, whereas NO generation occurs downstream from the K ATP channel.
MATERIALS AND METHODS
Cardiac culture preparation. Embryonic chick ventricular myocytes were prepared as described previously (44) . Spontaneously contracting cells on coverslips were studied at days 3-5 in a flow-through chamber under controlled O 2 and CO2 conditions on an inverted epifluorescence microscope (43) . The chamber and perfusate were maintained at 37°C; the flow rate was continuous (0.5 ml/min). Medium consisted of a balanced salt solution (BSS) with PO 2 of 100 mmHg, PCO2 of 40 mmHg, pH 7.4, K ϩ concentration ([K ϩ ]) of 4.0 meq/l, and 5.6 mM glucose. Simulated ischemia consisted of BSS without glucose, with 2-deoxyglucose (20 mM) to inhibit glycolysis and [K ϩ ] of 8.0 meq/l. This solution was bubbled with 80% N2-20% CO2 gas to produce PO2 of 7 mmHg, PCO2 of 144 mmHg, and pH 6.8. Hypoxic preconditioning medium consisted of BSS without glucose bubbled with 95% N2-5% CO2. Reperfusion was with normal medium with glucose.
Video fluorescent microscopy. Fluorescent images were captured with a 12-bit digital camera (Metamorph, Universal Imaging). Cell viability was quantified with Sytox Green (100 M; Molecular Probes), an exclusion fluorescent dye, to signal the loss of plasma membrane integrity associated with the loss of viability. This probe is not toxic to live cells, permitting its addition to the perfusate throughout. At the end of the experiment, cells were permeabilized with digitonin (300 M) to obtain a measure of 100% cell death. Cell death during the experiment was calculated as the percentage of cells exhibiting nuclear staining relative to the value after digitonin.
NO measurements. Endogenous NO production was assessed with the specific probe diaminofluorescein (DAF-2, 10 M; Calbiochem; Ref. 14) . After the cells are loaded with the diacetate form of the dye, covalent reaction with NO causes an increase in fluorescence. Fluorescence intensity was measured over time (excitation 480 nm, emission 520 nm) and expressed in arbitrary units.
Experimental design. The sequence of experimental interventions is shown in Fig. 2 . Cardiomyocytes were subjected to 60 min of simulated ischemia, followed by 180 min of reperfusion. Preconditioning was triggered by hypoxia (10 min), followed by 10 min of reoxygenation before ischemiareperfusion. Alternatively, preconditioning was triggered with H2O2 (15 M), PMA (200 nM), or pinacidil (10 M) for 10 min in lieu of hypoxia. The following compounds were added to the perfusate at different times: L-NAME (200 M), 5-hydroxydecanoate (5-HD, 500 M), Go-6976 (100 nM), ebselen (5 M), 2-mercaptopropionyl glycine (2-MPG, 400 M), trifluoperazine (50 M). Exogenous NO was supplied from a tank containing 1% NO-99% N2. This gas was added to the O2-CO2-N2 mixture used to bubble the perfusate, at a rate determined to achieve a final concentration of 200 nM of NO in the headspace gas. NO and NO2 concentrations were measured in the chamber every 10 min by chemiluminescence (Bedfont Scientific). Levels of NO2 generated from NO and O2 remained Ͻ2 ppm. -nitro-Larginine methyl ester; 2-MPG, 2-mercaptopropionyl glycine. Fig. 2 . Experimental protocols. All cells were subjected to 60-min ischemia, followed by 180-min reperfusion. Preconditioning was induced by exposure to a triggering stimulus (10 min) that was discontinued 10 min before ischemia. PC, hypoxic preconditioning; Trif, trifluoperazine.
Data analysis.
Replicate experiments were performed on separate coverslips, with each representing an n value of 1. Data are expressed as means Ϯ SE. Analysis of variance tests were performed, with P Ͻ 0.05 considered significant.
RESULTS
As seen previously with this model (43) , cell death was minimal during ischemia but rose to 58.1 Ϯ 2.9% (n ϭ 8) after 3-h reperfusion in nonpreconditioned cells. Preconditioning conferred significant protection regardless of whether the triggering stimulus was hypoxia (33.0 Ϯ 2.2%, n ϭ 10; P Ͻ 0.0001), the K ATP channel agonist pinacidil (29.9 Ϯ 2.0%, n ϭ 5; P Ͻ 0.0001), exogenous H 2 O 2 (36.7 Ϯ 3.5%, n ϭ 6; P ϭ 0.0005), or PMA (26.2 Ϯ 1.3%, n ϭ 3; P ϭ 0.0001) (Fig. 3) .
Role of ROS and PKC in opening of mitoK ATP channel during triggering. Hypoxic preconditioning requires ROS generation from the mitochondrial electron transport chain, and exogenous H 2 O 2 given during normoxia also confers protection (42) . If these ROS cause activation of the mitoK ATP channel, then inhibitors of that channel should abrogate the protection they confer. In the present study, the mitoK ATP channel inhibitor 5-HD given throughout the experiment abolished protection induced either by hypoxia (55.5 Ϯ 1.4%, n ϭ 4) or by exogenous H 2 O 2 (64.9 Ϯ 7.2%, n ϭ 6), thereby confirming the requirement for K ATP channel opening in these responses (Fig. 3A) . Protection was also abrogated when 5-HD was administered only during baseline and triggering associated with hypoxic (57.3 Ϯ 5.5%, n ϭ 3) or exogenous H 2 O 2 (54.0 Ϯ 1.6%, n ϭ 3) preconditioning. These findings implicate ROS in the signaling that occurs upstream of the mitoK ATP channel during triggering (Fig. 1) .
Previous investigators have proposed that PKC promotes activation of the K ATP channel during triggering (17, 36, 39) . In this study, cells preconditioned with the PKC activator PMA exhibited significant protection compared with nonpreconditioned cells. Addition of 5-HD throughout the study abolished this protection (Fig. 3A) . Furthermore, PKC inhibition by Go-6976, a selective PKC inhibitor, blocked the protection conferred by H 2 O 2 (P ϭ 0.01; Fig. 3B ) but did not block protection induced by pinacidil. These results are consistent with the proposed activation of PKC by ROS at a site upstream from the mitoK ATP channel (Fig. 1) .
Role of NO in preconditioning triggering. To clarify whether NO participates in the signaling during triggering, L-NAME was given throughout the study to inhibit NO synthase. This compound abolished the protection conferred by hypoxic preconditioning (52.7 Ϯ 1.5% cell death, n ϭ 5; Fig. 4A ), by pinacidil (54.5 Ϯ 3.4%, n ϭ 5; Fig. 4B ), and by exogenous H 2 O 2 (56.1 Ϯ 1.0%, n ϭ 3; not shown). Preliminary studies showed that lower concentrations (50-100 M) of L-NAME did not abolish protection (data not shown). When given only during baseline and triggering, L-NAME also abolished protection by pinacidil (52.5 Ϯ 1.6%, n ϭ 3) and by PMA (60.7 Ϯ 2.2%, n ϭ 3). Protection was also abolished when NOS was inhibited by the calmodulin inhibitor trifluoperazine given only during baseline and triggering (52.7 Ϯ 3.7%, n ϭ 3). These findings are consistent with the proposed involvement of NO in the signaling associated with multiple triggers, at a site that must occur downstream from the opening of the K ATP channel (Fig. 1) .
To clarify the requirement for NO during triggering, exogenous NO was added to the gas mixture used to bubble the media during baseline and triggering. The NO was begun before triggering to allow the NO concentration to reach the target value of 200 nM. That concentration was selected on the basis of the preliminary dose-response observation that intracellular sig- naling was activated but that mitochondrial potential was maintained (not shown). In cells treated throughout the experiment with L-NAME, exogenous NO restored protection conferred by hypoxia (24.5 Ϯ 4.4%, n ϭ 4; Fig. 4A ) or pinacidil (28.5 Ϯ 2.4%, n ϭ 4; Fig.  4B ). Furthermore, this ability to restore protection was not abolished by concomitant administration of 5-HD in cells treated with L-NAME and preconditioned by hypoxia (33.1 Ϯ 1.5%, n ϭ 3; Fig. 4A ). These findings are consistent with the involvement of NO in the triggering of preconditioning at a site downstream from the K ATP channel activation (Fig. 1) .
Administration of exogenous NO to hypoxic preconditioned cells restored the protection (26.7 Ϯ 3.1%, n ϭ 4) that had been abrogated by 5-HD (55.5 Ϯ 1.4%, n ϭ 4; P ϭ 0.0001; Fig. 4C ). Similarly, protection triggered by exogenous H 2 O 2 (36.7 Ϯ 3.5%) was abrogated by 5-HD (64.9 Ϯ 7.2%) but was restored when exogenous NO was given only during baseline and triggering (25.1 Ϯ 2.7%, n ϭ 3; Fig. 4C ). These findings are consistent with the proposed involvement of ROS upstream from the mitoK ATP channel and the requirement for NO downstream from that site during the triggering phase (Fig. 1) .
If NO is required for the triggering of preconditioning, and if NO generation is regulated by the opening of the K ATP channel, then induction of preconditioning by either hypoxia or pinacidil should stimulate NO generation. Figure 5A shows the effects of repeated 10-min exposures to hypoxia on DAF-2, which becomes fluorescent on combination with NO. The increase in DAF-2 fluorescence was inhibited by L-NAME at 200 M but not by lower concentrations (50 M). The increase was also blocked by trifluoperazine, which attenuates NOS activity by inhibiting calmodulin (Fig.  5A) . The increase in DAF-2 fluorescence during hypoxia was also attenuated by 5-HD (Fig. 5B) . In the presence of pinacidil, this response was significantly amplified (Fig. 5C) . Collectively, these observations confirm that DAF-2 is sensitive to NO production, and they support the proposed relationship between the activation of the mitoK ATP channel by hypoxia or pinacidil and the resulting stimulation of NOS activity during triggering (Fig. 1) .
Production of ROS and NO as consequence of mito-K ATP channel activation. mitoK ATP channel activation (6, 31) and NO (27) have each been suggested to trigger preconditioning through a free radical-mediated mech- Fig. 4 . Cell death and the effects of preconditioning. A: NO synthase (NOS) inhibitor L-NAME (200 M) given throughout the experiment abrogated preconditioning-induced protection (n ϭ 5). Exogenous NO (200 nM) administered during baseline and PC triggering restored protection that was abrogated by L-NAME treatment (n ϭ 4). The KATP channel inhibitor 5-HD (500 M) did not abolish the ability of NO to rescue protection in cells treated with L-NAME (n ϭ 3). * P Ͻ 0.0001 vs. control. B: preconditioning with pinacidil (10 M, n ϭ 5) significantly reduced cell death compared with nonpreconditioned control cells. Treatment with L-NAME abolished the protective effect of pinacidil (n ϭ 5), but exogenous NO during baseline and triggering restored protection (n ϭ 4). * P Ͻ 0.0001 vs. control. C: treatment with 5-HD throughout the experiment abolished the protective effect of hypoxic and H2O2 (15 M) triggering (n ϭ 6 for each group). Protection was restored by exogenous NO given during baseline and triggering (n ϭ 3). * P Ͻ 0.001 vs. control.
anism (31) . To test this, exogenous NO was administered to nonpreconditioned cells during baseline and triggering. This conferred significant protection (Fig.  6A) , which was abrogated by the antioxidant 2-MPG. Protection by NO was also abolished when 5-HD was given during baseline and triggering. This is consistent with the ability of exogenous NO to activate the mito-K ATP channel (35) .
Compared with nonpreconditioned cells (58.1 Ϯ 2.9%, n ϭ 10), exogenous NO only partially restored protection in PMA-preconditioned cells whose mitoK ATP channels were inhibited by 5-HD (46.7 Ϯ 0.8%, n ϭ 3, P ϭ 0.04; Fig. 6B ). However, exogenous NO plus H 2 O 2 during triggering completely restored protection conferred by PMA in 5-HD-treated cells (n ϭ 3; Fig.  6B ). These findings are consistent with the proposed requirement for both NO and ROS in signaling distal to the K ATP channel (Fig. 1) .
To confirm the requirement for ROS downstream from the K ATP channel, ebselen, a glutathione peroxidase mimetic, was administered only during 10-min pinacidil triggering. Ebselen accelerates conversion of H 2 O 2 to H 2 O (38), and it abolished the protection conferred by pinacidil (53.0 Ϯ 2.0%, n ϭ 3; Fig. 6C ). To further confirm the requirement for ROS downstream from the mitoK ATP channel, 2-MPG was administered with the same protocol. 2-MPG also abrogated protection in pinacidil-treated cells (n ϭ 3; Fig. 6C ). These findings are consistent with the proposed involvement of ROS in signaling downstream from the K ATP channel (Fig. 1) .
DISCUSSION
This study examined the relationships among ROS, NO, PKC, and the mitoK ATP channel during the triggering of preconditioning. Preconditioning by hypoxia, H 2 O 2 , or PMA conferred protection that was blocked by mitoK ATP channel inhibition (Fig. 1) . Therefore, the signals activated by these triggers must precede opening of the K ATP channel. The data also reveal that NO is required during triggering, based on the observations that 1) hypoxia-, H 2 O 2 -, or PMA-induced protection was blocked by NOS inhibitors, 2) exogenous NO restored protection that had been abrogated by NOS inhibition, and 3) fluorescence of the NO-sensitive probe DAF-2 increased during triggering. The stimulation of NO production during triggering must have been a consequence of K ATP channel activation because 1) inhibitors of that channel attenuated the DAF-2 response, 2) protection induced by pinacidil was abolished by NOS inhibition, 3) pinacidil was associated with an augmentation of DAF-2 fluorescence, and 4) exogenous NO restored protection that had been abolished by 5-HD treatment in preconditioned cells.
These conclusions are based on the assumption that the inhibitors used in the study were specific for their intended targets. Several pharmacological agents used in the study of ischemic preconditioning have been shown to act at nonspecific sites, which could confound interpretation of this study. For example, Hanley et al. (11) recently reported that 5-HD acts as a substrate for acyl-CoA synthetase, that pinacidil selectively inhibits NADH oxidation, and that diazoxide can inhibit succinate dehydrogenase. Although it is not clear how these nonspecific targets could explain the effects of these drugs on preconditioning protection, it is clear is that future confirmation of the findings of our study will require the use of more definitive tools.
ROS signaling upstream of K ATP channel. We (42) and others (1, 2, 41) have found that oxidant signals contribute to hypoxia-induced preconditioning. The ROS signal during hypoxic triggering was abolished by complex III inhibitors, which implicates the mitochondria in the oxidant generation (42) . ROS signals appear to contribute to the activation of the K ATP channel during certain types of preconditioning. Recently it was shown that superoxide can activate reconstituted mitoK ATP channels in a planar lipid bilayer (51) . In our study, hypoxia-or H 2 O 2 -induced protection was abolished by 5-HD given either throughout the study or only during the triggering phase. However, K ATP channel inhibition did not abolish the ROS signal during hypoxic triggering (42) . Therefore, at least some of the oxidant signaling during hypoxic triggering does not require opening of the K ATP channel (Fig. 1) .
Requirement for ROS downstream from mitoK ATP channel. Data also suggest that K ATP channel opening causes ROS generation. Pain et al. (31) found that antioxidants blocked protection induced by diazoxide, whereas Forbes et al. (6) found direct evidence of ROS generation in response to that K ATP channel opener. Our finding that antioxidants abolished pinacidil-induced protection is consistent with their conclusions. During ACh-induced preconditioning, Yao et al. (50) found that K ATP channel inhibition abolished both protection and the oxidant signal during triggering, suggesting that ROS must have been generated downstream from that channel. In cells preconditioned with opioid agonists, 5-HD also abolished the ROS signals and protection during triggering (23) . Therefore, preconditioning by K ATP channel agonists or certain receptor-mediated triggers causes K ATP channel opening and subsequent ROS signaling. Hence, with certain triggers ROS do not appear to be involved until after the K ATP channel opens (Fig. 1) .
Relationship between ROS and PKC activation. The targets of PKC during the induction of preconditioning are not known. The notion that oxidants precede PKC activation is consistent with the observation that ROS can activate PKC (8, 37) . Moreover, PKC inhibitors block protection without altering the ROS signal during hypoxic triggering (43) , indicating that PKC acts upstream from the K ATP channel but downstream from Fig. 6 . Cell death and the effects of preconditioning. A: exogenous NO conferred significant cardioprotection (n ϭ 3) that was blocked by 5-HD (n ϭ 4) or by 2-MPG (400 M, n ϭ 3) *P Ͻ 0.001 vs. control. B: 5-HD given throughout the study abolished PMA-induced protection (200 nM, n ϭ 3). Protection was partially restored by exogenous NO (200 nM, n ϭ 3) and was fully restored by the coadministration of exogenous NO and H2O2 (15 M) during triggering (n ϭ 3). * P Ͻ 0.05 vs. control. C: pinacidil given only during triggering conferred significant protection that was abolished by the ROS scavengers ebselen (5 M) and 2-MPG (400 M) (n ϭ 3 for each group). * P Ͻ 0.0001 vs. control.
hypoxia-activated mitochondrial ROS generation (Fig.  1) . Protection by exogenous H 2 O 2 was abolished by PKC inhibition, indicating that ROS can potentially trigger preconditioning by promoting the activation of PKC. However, PKC inhibition did not block protection by pinacidil, indicating that PKC must be acting upstream from the K ATP channel. Furthermore, protection induced by PKC activation was abolished by 5-HD, indicating that protection by PKC required the opening of the K ATP channel. Collectively these observations indicate that ROS signals generated during hypoxia or H 2 O 2 triggering are proximal to PKC activation (40) . Furthermore, PKC induces protection through a mechanism requiring K ATP channel activation (Fig. 1) .
Liu et al. (17) reported that PKC activation can potentiate the K ATP current induced by pinacidil, and Sato et al. (36) demonstrated that PKC primes the K ATP channel to open earlier and more intensively during prolonged ischemia. Wang et al. (45) showed that PKC downregulation renders the K ATP channel ineffective, thereby augmenting ischemic injury. These findings are consistent with a model in which PKC and the K ATP channel are interrelated, with PKC acting as a regulator of that channel (Fig. 1) . It is possible that ROS generated in response to K ATP channel opening could augment PKC activation, which in turn could feedback to facilitate or prolong channel activity. Our findings confirm the linkage between PKC and activation of the K ATP channel and extend previous work by linking this pathway to the early ROS and RNS bursts produced by various triggering agents.
Requirement for NO in early preconditioning. The role of NO in early preconditioning is controversial. In some studies, NOS inhibitors failed to abolish preconditioning-induced protection in rats (24, 46) , rabbits (27, 47) , and pigs (33) . In the rat heart, Weselcouch et al. (46) found that protection was not blocked by L-NAME at 30 M, yet Lochner et al. (19) were able to block protection with 50 M. Nakano et al. (27) found that NO donors induced preconditioning in the rabbit heart but were unable to abolish protection with L-NAME at 100 M. We found that L-NAME inhibited protection at 200 M, but preliminary studies failed to show any effect at 50 or 100 M. Thus dose-dependent effects of NOS inhibitors may explain, at least in part, the negative results observed in some previous reports.
Our data indicate that NO is generated during triggering, and the resulting signal is required for protection. Endothelial type NOS is constitutively expressed in cardiomyocytes (3, 25) , and an isoform of NOS similar to the endothelial isoform is expressed in cardiac mitochondria (7, 20) . This places a potential source of NO in close proximity to the mitoK ATP channel. In conscious rabbits, Xuan et al. (48) observed a rapid activation of calcium-dependent NOS after repeated cycles of hypoxia were used to trigger late preconditioning. Early preconditioning can be induced by the same triggering protocol (12) , raising the possibility that NO generation during preconditioning involves Ca 2ϩ /calmodulin-dependent NOS activation. Our finding that protection was abrogated when NOS was blocked with the calmodulin inhibitor trifluoperazine is consistent with that possibility.
ROS and NO signals during triggering: relationship to mitoK ATP channel. Our data suggest that K ATP channel activation triggers NO production. First, pinacidilinduced protection was abolished by L-NAME, and protection was restored by exogenous NO during triggering. Second, hypoxia-simulated NO production was abolished by K ATP channel inhibition and was amplified by K ATP channel openers. These findings indicate that NO generation is regulated by the K ATP channel (Fig. 1) . In rabbits, Ockaili et al. (29) reported that diazoxide mimicked both early and delayed preconditioning and that L-NAME applied before the sustained ischemia blocked protection. Our conclusion that NO is a mediator of protection regulated by K ATP channel activation is therefore consistent with their data.
Other studies show that exogenous NO facilitates K ATP channel activation (35) , which suggests that the channel can be a target of endogenous NO production. In our study, exogenous NO was protective and this effect was blocked by 5-HD, suggesting that NO protected by opening that channel (35) . Activation of the mitoK ATP channel also triggers ROS production (6, 31), so 5-HD may have blocked protection because it prevented the ROS generation normally triggered by mitoK ATP opening. In support of this interpretation, we found that protection induced by pinacidil was reversed by the antioxidants 2-MPG and ebselen, confirming that ROS are required downstream from mitoK ATP channel. Also, exogenous H 2 O 2 given with NO conferred protection when the mitoK ATP was blocked. Finally, the protective effect of exogenous NO was abolished by the antioxidant 2-MPG. Collectively these results indicate that exogenous NO can lead to opening of the mitoK ATP channel. The opening of that channel then leads to the generation of ROS and NO, both of which are required for preconditioning. During hypoxic triggering, NO and ROS produced by mitoK ATP channel opening could feedback on the channel itself, thereby prolonging its activation and facilitating the downstream effects, including the further generation of ROS and NO.
Requirement for ROS and RNS downstream from mitoK ATP channel. Further evidence supporting the need for both ROS and NO downstream from the K ATP channel came from cells preconditioned with PMA. In these cells, 5-HD blocked protection but a small degree of preconditioning was restored when exogenous NO was also given (Fig. 6B) . If PMA protects by activating the K ATP channel via PKC, then 5-HD should abolish protection (Fig. 1) . In that situation, exogenous NO should fail to restore significant protection because of the lack of a simultaneous ROS signal. However, when both H 2 O 2 and exogenous NO were administered, full protection was restored because both the ROS and NO arms were present. By the same reasoning, in cells preconditioned with H 2 O 2 or hypoxia and blocked with 5-HD, exogenous NO was able to restore protection because the triggers were able to supply the necessary ROS component of signaling (Fig. 4C) . Therefore, ex-ogenous H 2 O 2 and NO given together confer protection even if the K ATP channel is blocked, because these molecules appear to act downstream of the channel in the hypoxic preconditioning process. We conclude that preconditioning triggers such as hypoxia or exogenous H 2 O 2 can induce protection by causing activation of the mitoK ATP channel via oxidant signaling. Protection ensues when NO and additional ROS are generated as a result of K ATP channel opening. Triggers such as PMA or pinacidil can trigger K ATP opening without the need for ROS upstream from the channel. Once opened, the K ATP channel stimulates downstream production of ROS and NO, both of which are required for protection. Scavenging of either the NO or ROS signals generated downstream from the K ATP channel was sufficient to abolish protection.
Oxidant signaling during triggering versus oxidant stress at reperfusion. Our data implicate both NO and ROS in the redox signaling involved in the induction of preconditioning. We previously observed (43) a large burst of oxidative stress at the start of reperfusion. This burst was smaller in preconditioned cells, which showed an improvement in survival. This illustrates the paradoxical involvement of ROS and NO in ischemia-reperfusion injury, with small redox-dependent signals involved in the induction phase and large bursts of oxidant stress contributing to cell death during ischemia and reperfusion.
The mechanism responsible for protection in preconditioning is not known. We speculate that ROS and NO are protective because they inhibit the process of cell injury during ischemia that leads to the uncontrolled oxidant burst generated at reperfusion. Although some protection is achieved if an antioxidant cocktail is administered only during reperfusion (43) , the full significance of the oxidant burst at reperfusion is not clear. Although the burst is attenuated in preconditioned cells, it is not known whether the burst represents the cause of cell death or whether it is merely a marker of irreversible injury. To the extent that cell death in this model occurs through an apoptotic pathway, it is possible that NO and ROS signals act to inhibit the release of apoptosis-inducing proteins from the intermembrane space of mitochondria or that they inhibit the activation of caspases. In either case, the degree of protection appears to be greater in the intact heart, where 60-80% reduction in cell death can be achieved with preconditioning compared with the 40-50% seen in our cardiomyocyte model. Regardless of the model used, future progress in revealing the mechanisms of preconditioning protection will require a clearer understanding of the sequence of events that commit cells to a death pathway in ischemia and reperfusion.
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